CD8+ T-cell responses to adeno-associated virus capsid in humans
Top Cited Papers
- 18 March 2007
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 13 (4) , 419-422
- https://doi.org/10.1038/nm1549
Abstract
Hepatic adeno-associated virus (AAV)-serotype 2 mediated gene transfer results in transgene product expression that is sustained in experimental animals but not in human subjects. We hypothesize that this is caused by rejection of transduced hepatocytes by AAV capsid-specific memory CD8(+) T cells reactivated by AAV vectors. Here we show that healthy subjects carry AAV capsid-specific CD8(+) T cells and that AAV-mediated gene transfer results in their expansion. No such expansion occurs in mice after AAV-mediated gene transfer. In addition, we show that AAV-2 induced human T cells proliferate upon exposure to alternate AAV serotypes, indicating that other serotypes are unlikely to evade capsid-specific immune responses.Keywords
This publication has 8 references indexed in Scilit:
- Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsidNature Medicine, 2006
- Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseNature Medicine, 2006
- Identification of mouse AAV capsid-specific CD8+ T cell epitopesMolecular Therapy, 2005
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyProceedings of the National Academy of Sciences, 2002
- Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapyBlood, 2002
- Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infectionsNature Medicine, 2002
- Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in LiverMolecular Therapy, 2000
- Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsNature Medicine, 1999